Qiming U.S. Ventures Management’s Kezar Life Sciences KZR Stock Holding History

Qiming U.S. Ventures Management’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$323K	Hold	82,871	–	–	0.58%	4
2025 Q2	$380K	Hold	82,871	–	–	1.61%	6
2025 Q1	$404K	Hold	82,871	–	–	1.75%	6
2024 Q4	$557K	Hold	82,871	–	–	1.09%	6
2024 Q3	$638K	Hold	82,871	–	–	1.24%	6
2024 Q2	$497K	Hold	82,871	–	–	0.94%	6
2024 Q1	$747K	Hold	82,871	–	–	0.83%	6
2023 Q4	$785K	Hold	82,871	–	–	0.72%	8
2023 Q3	$986K	Hold	82,871	–	–	1.31%	7
2023 Q2	$2.03M	Hold	82,871	–	–	2.13%	7
2023 Q1	$2.59M	Hold	82,871	–	–	3.14%	7
2022 Q4	$5.83M	Hold	82,871	–	–	7.72%	4
2022 Q3	$7.13M	Hold	82,871	–	–	10.36%	5
2022 Q2	$6.85M	Hold	82,871	–	–	9.51%	5
2022 Q1	$13.8M	Hold	82,871	–	–	12.94%	4
2021 Q4	$13.9M	Buy	+82,871	New	+$9.36M	6.38%	6

Other funds holding KZR

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Qiming U.S. Ventures Management's KZR Position: Q3 2025 in Review

Qiming U.S. Ventures Management held its Kezar Life Sciences (KZR) position steady in Q3 2025 at 82,871 shares worth $323K. The position accounts for 0.58% of the portfolio, ranked #4.

Qiming U.S. Ventures Management first reported a position in KZR in Q4 2021 and has held it in 16 quarters since. The position peaked at $13.9M in Q4 2021. 39 funds tracked by Wall St. Rank hold KZR as of Q3 2025.

Qiming U.S. Ventures Management held 82,871 shares of Kezar Life Sciences worth $323K as of Q3 2025.
Qiming U.S. Ventures Management left its Kezar Life Sciences share count unchanged in Q3 2025.
Kezar Life Sciences made up 0.58% of Qiming U.S. Ventures Management's portfolio in Q3 2025, its #4 holding.
Qiming U.S. Ventures Management first reported a position in Kezar Life Sciences in Q4 2021 and has held it in 16 quarters since.
Qiming U.S. Ventures Management's Kezar Life Sciences position peaked at $13.9M in Q4 2021.
39 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2025.

Based on Qiming U.S. Ventures Management's 13F filing for Q3 2025, filed 10 Nov 2025.